OrthoGrid Systems and nView medical Partnering Annnounce Partnership

Announced today, nView medical, a leading innovator in 3D medical imaging, and OrthoGrid Systems, a global MedTech leader offering intraoperative alignment technologies, are partnering to provide integrated solutions that increase surgical accuracy and OR efficiency and improve patient outcomes.

As the first step for implementation, the companies are executing a proof of concept for a periacetabular osteotomy (PAO) procedure, and, after completion, will expand to additional musculoskeletal procedures. PAO surgery aims to preserve the hip joint by repositioning the native acetabulum, a complex pediatric joint preservation surgery that aims to reduce or eliminate the risk of a future total hip replacement. OrthoGrid offers the first PAO-specific, imaging-based, surgical navigation application on the market.

“Many problems in orthopedic surgery are 3D problems. Currently, they are solved based on 2D imaging data,” says Dr. Chris Peters, Professor of Orthopaedics at the University of Utah and a renowned hip preservation specialist. “Being able to merge OrthoGrid’s Hip Preservation application with nView’s real-time, 3D, intraoperative imaging data would bring new and valuable information during critical surgical steps, such as the acetabular osteotomy and positioning.”

Both nView medical and OrthoGrid technologies are AI-driven, open platforms designed to work within the surgical theater to improve accuracy, workflow efficiency, and patient outcomes. With the nView 3D imaging data, planning can be achieved intraoperatively, reducing the need for preoperative planning. Similarly, postoperative alignment verification via x-rays may be avoided, and overall radiation exposure to young patients is expected to reduce drastically.

“We are thrilled to engage in this partnership with OrthoGrid, as we truly have aligned company missions: To enhance surgeons’ experience in the OR while simultaneously working to improve patient outcomes,” said Cristian Atria, Founder and CEO at nView Medical. “OrthoGrid’s expert knowledge of procedural steps and intraoperative problem-solving, along with their commitment to AI-driven, imaging-based automation, is an intuitive next step to further expand the opportunity behind real-time, 3D images. We look forward to seeing the immense impact combining these two innovations will have on musculoskeletal procedures in the years to come.”

“This partnership combines two technological needs within intraoperative imaging: Real-time, 3D imaging, and procedural decision making into one unique solution,” said Edouard Saget, Co-Founder, and Co-CEO at OrthoGrid Systems. “We seek to optimize the value equation in orthopedics, one of OrthoGrid’s long-term commitments. By integrating our applications within nView’s 3D imaging system, we are consolidating the number of devices required in the operating room, thus improving operating room efficiency, staff training, and the overall value proposition to the hospital. At the end of the day, we’re always working to make surgeons’ experience in the OR as seamless as possible.”

Hot this week

Cartessa Aesthetics Partners with Classys to Bring EVERESSE to the U.S. Market

Classys, which is listed on the KOSDAQ, is one of South Korea's most distinguished aesthetic technology manufacturers, with devices distributed in 80+ markets globally. This partnership marks Classys's official entry into the American marketplace, with Cartessa Aesthetics as the exclusive distributor for EVERESSE, launched under the Volnewmer brand in current global markets.

Stryker Launches Next-Generation of SurgiCount+

Now integrated with Stryker's Triton technology, SurgiCount+ addresses two key challenges: retained surgical sponges and blood loss assessment. Integrating these previously separate digital solutions provides the added benefit of a more efficient, streamlined workflow for hospitals notes Stryker.

Nevro Receives CE Mark In Europe for It’s HFX iQ™ Spinal Cord Stimulation System

Nevro notes HFX iQ is the first and only SCS system with artificial intelligence (AI) technology that combines high-frequency (10 kHz) therapy built on landmark evidence that uses ongoing cloud data insights to deliver personalized pain relief

Recor Medical Reports: CMS Grants Distinct TPT Device Code and Category to Recor Medical for Ultrasound Renal Denervation

The approval of TPT offers incremental reimbursement payments for outpatient procedures performed with ultrasound renal denervation for Medicare fee-for-service beneficiaries. It becomes effective January 1, 2025, and is expected to remain effective for up to three years notes Recor Medical.

Jupiter Endovascular Reports | 1st U.S. Patient Treated with Jupiter Shape-shifting Thrombectomy Device

“Navigation challenges during endovascular procedures are often underappreciated and have led to under-adoption of life-saving procedures, such as pulmonary embolectomy. We have purpose-built our Endoportal Control technology to solve these issues and make important endovascular procedures accessible to more clinicians and their patients who can benefit from them,” said Carl J. St. Bernard, Jupiter Endovascular CEO. “This first case in the U.S. could not have gone better, and appears to validate the safety and performance we are seeing in our currently-enrolling European SPIRARE I study.”